Key takeaways
A true generic version of Ozempic won’t be available until at least 2033, as the drug is still under patent protection.
Some compounded semaglutide options are marketed as cheaper alternatives but are not FDA-approved and may carry safety risks.
Wegovy, Rybelsus, and other brand-name drugs contain semaglutide but do not have generic versions yet, making them potentially expensive options.
Many people are interested in a generic version of Ozempic (semaglutide), especially since the brand-name drug can cost over $1,300 per month without insurance. Ozempic is approved to manage Type 2 diabetes, reduce the risk of heart attacks and strokes in people with heart disease, and reduce the risk of worsening kidney disease. It is also commonly prescribed off-label for weight loss. A true generic version of Ozempic isn’t expected in the U.S. until at least 2033 due to patent protection, although compounded versions of semaglutide have been available as lower-cost options that are not approved by the Food and Drug Administration (FDA).
Ozempic generic availability |
|
|---|---|
| Generic name | Semaglutide |
| Is there a generic available for sale in the U.S.? | No |
| When will a generic be available? | Early 2030s after patents expire |
Generic Ozempic: A misleading term
When people talk about “generic Ozempic,” it can be confusing. Generic drugs usually come into the market after the original drug’s patent expires, allowing competition. However, Novo Nordisk still has patent exclusivity for Ozempic, at least until 2033. This means no drugmakers are producing a true generic version of Ozempic that’s approved by the FDA.
Some products might claim to be generic versions, but they aren’t FDA-approved. These are often sold as compounded drugs containing the same active ingredients as brand-name drugs. Compounding involves customizing medications for specific needs, potentially in different strengths and dosage forms. But the result isn’t the same as having a generic option.
Without FDA approval, there is no guarantee that these medications will offer the same safety and effectiveness as the brand-name drug. Therefore, it’s important to use caution and consult a healthcare provider when considering these alternatives.
Save up to 80% on Ozempic with SingleCare
Different pharmacies offer different prices for the same medication. SingleCare helps find the best price for you.
What are the differences between semaglutide and Ozempic?
Semaglutide is the active ingredient in Ozempic, which can cause some confusion. The confusion arises because semaglutide is often mentioned as if it were the same as Ozempic, leading people to mistakenly think they are the same or that a generic version of Ozempic is available. Although semaglutide is the generic name for Ozempic, there is currently no approved generic version of Ozempic available.
Semaglutide is part of a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. These drugs help manage blood sugar levels in people with Type 2 diabetes and support weight loss. While Ozempic may be a well-known GLP-1 agonist that contains semaglutide, it’s not the only brand-name drug that contains semaglutide.
The following brand-name medications contain semaglutide that is given in different dosages or dosage forms:
- Wegovy is a brand-name medication containing semaglutide. Unlike Ozempic, which is approved for Type 2 diabetes, Wegovy is approved specifically for weight loss in adults and adolescents ages 12 and older. It also gained approval for a certain type of liver disease (MASH) and reduced risks of cardiovascular death, heart attacks, and strokes in adults with obesity or who are overweight with known heart disease. Like Ozempic, Wegovy is taken as a once-weekly injection, but it delivers a higher dose of semaglutide. It’s also available as an oral tablet.
- Rybelsus is a different brand-name option that offers semaglutide in pill form. It’s taken orally and is also used to help control blood sugar in people with Type 2 diabetes. Rybelsus may be convenient for those who prefer pills over injections.
Like Ozempic, these other brand-name drugs are not yet available in generic versions. As a result, these medications can be expensive. In addition, while they help many people manage conditions like diabetes and obesity, how well they work can differ from person to person.
Wegovy coupons, Rybelsus coupons
Compounded semaglutide and its ingredients
For much of 2023 and 2024, the demand for semaglutide was so high that brand-name versions like Ozempic and Wegovy were in short supply. As more people turned to these medications for their effectiveness, pharmacies often struggled to keep enough in stock. Drug shortages can make it hard for people to get the treatment they need when they need it.
Compounding pharmacies specialize in making customized medications for patients. This means pharmacists might combine or adjust ingredients for specific health needs. For instance, they might change the dosage or eliminate certain ingredients for those with allergies. Those who had trouble finding Ozempic during the shortage sometimes turned to a compounding pharmacy offering a custom version of semaglutide.
In addition to semaglutide as the active ingredient, compounded semaglutide products might contain the following:
- Inactive ingredients, such as:
- Buffers: To maintain the pH level and stability of the solution
- Preservatives: To prevent microbial growth
- Solvents: To help dissolve the semaglutide and facilitate its administration, often including water for injection or saline
- Potential additives, such as:
- Stabilizers: To ensure the medication remains effective over time
- Colorants or flavorings: For palatability, particularly in oral formulations
On Feb. 21, 2025, the FDA determined that semaglutide was no longer in short supply and gave compounding pharmacies a deadline to cease distributing compounded versions of semaglutide that are essentially identical to FDA-approved Ozempic and Wegovy. The deadline was Apr. 22, 2025, for state-licensed pharmacies and physicians, and May 22, 2025, for outsourcing facilities. As a result, widespread access to compounded semaglutide through these pharmacies has largely ended.
Is compounded semaglutide safe?
Compounded semaglutide is becoming more popular as people search for alternatives to expensive medications like Ozempic. Some compounding pharmacies offer their versions, claiming they contain the same active ingredient. However, it’s important to consider if these compounded drugs are truly safe.
Healthcare providers often stress the importance of clinical trials to establish a drug’s safety and effectiveness. Compounded semaglutide does not undergo these trials, so there may be unknown risks. People using compounded versions should know they are taking a medication that hasn’t been FDA approved and hasn’t gone through the extensive testing typical for approved medications.
Potential risks with compounded semaglutide
The FDA has warned against using compounded forms of semaglutide, citing safety concerns. Some people have experienced negative health effects, with some needing to go to the hospital due to mistakes in measuring their doses. These errors can happen when patients try to self-administer the medication or when healthcare providers miscalculate the amounts needed.
Additionally, many patients who use compounded semaglutide are not familiar with self-injections. This lack of experience, combined with confusion over units such as milliliters and milligrams, may lead to dosing errors. Therefore, it’s key to know how to measure and inject the medication properly.
To reduce these risks, the FDA recommends that patients consult their healthcare providers or pharmacists to learn how to measure and administer the correct dose accurately. Having the right syringe size and clear dosage instructions can play a big part. It’s also important to be aware of the different strengths available for compounded semaglutide.
Other FDA concerns with compounded semaglutide
Another problem with compounded semaglutide is that some compounding pharmacies use different salt forms of semaglutide, like semaglutide sodium and semaglutide acetate. These are not the same as the approved version, which uses the base form of semaglutide. The FDA has pointed out that there is no good reason for using these salt forms in compounded drugs, as they do not meet the legal requirements for what can be compounded.
Patients should be careful when considering any products labeled as semaglutide. Some may contain unapproved salt forms that have not been proven safe or effective. It’s important to get semaglutide only with a prescription from a licensed healthcare provider and to buy it from state-licensed pharmacies or facilities registered with the FDA.
Side effects of compounded semaglutide
The possible side effects of compounded semaglutide are generally the same as those of brand-name versions, such as Ozempic. The most common side effects of semaglutide include gastrointestinal ones like nausea, vomiting, stomach pain, constipation, and diarrhea.
In addition to these common side effects, semaglutide carries a boxed warning for thyroid tumors based on animal studies. It is not completely known whether semaglutide causes thyroid cancer in humans, but the drug should be avoided in people with a personal or family history of thyroid cancer.
Pancreatitis is another potential adverse effect that can be serious. If you experience severe abdominal pain that doesn’t go away, with or without vomiting, stop using the medication and call your healthcare provider right away.
Other potential serious side effects include changes in vision and kidney problems. Low blood sugar levels may also occur, especially if you’re taking other medications that lower blood sugar. Symptoms of low blood sugar include dizziness, confusion, and weakness. Compounded semaglutide may also cause allergic reactions. If you notice signs of a severe allergic reaction, such as swelling, difficulty breathing, or a severe rash, seek medical help immediately.
Other side effects may occur depending on the other ingredients in the preparation. The potential lack of precise ingredient measurements in compounded versions may increase the risk of adverse effects.
Be cautious with compounded semaglutide online
Buying Ozempic or compounded semaglutide online might seem like a cheaper option, but there are important risks to consider. Some websites advertise lower prices, but the quality may vary.
Some compounding pharmacies might source materials from places like China, which can raise quality questions. American pharmaceutical companies typically follow stricter manufacturing guidelines, which may offer greater assurance. Make sure that any compounded medication comes from a reputable source.
Choosing compounded semaglutide with medical guidance
Compounded semaglutide may be a helpful option for specific patient needs (for example, a different dosage strength or allergen-free formulation), but it’s important to be careful when considering it. Now that the FDA is enforcing its deadlines for pharmacies to stop producing compounded versions that are essentially copies of Ozempic and Wegovy, these products may become harder to get.
Here are some simple steps to ensure that compounded semaglutide is safe for you:
- Talk to a healthcare provider. Before starting, consult a qualified healthcare professional, such as your primary care doctor or an endocrinologist. They can provide advice based on your health situation.
- Check the pharmacy. Make sure the pharmacy you choose is licensed and follows proper guidelines for compounding medications. This helps ensure the product is made safely and with the right ingredients.
- Look for FDA warnings. Check whether there are any updated warnings from the FDA about compounded semaglutide. This information may help you avoid potential risks.
- Discuss side effects. Have a conversation with your healthcare provider about possible side effects and any interactions with other medications you might be taking.
Choosing compounded semaglutide should always be done with the help of a medical professional who is familiar with your health history and medical needs. This way, you can carefully consider the benefits and any safety concerns.
Generic alternatives to Ozempic
Various GLP-1 receptor agonists are available for managing Type 2 diabetes or supporting weight loss. These medications work in similar ways to improve insulin secretion, slow stomach emptying, and reduce appetite.
Here’s a look at other GLP-1 receptor agonists and dual GIP/GLP-1 agonists besides Ozempic:
- Victoza: Victoza is a medication containing liraglutide used to improve blood sugar control in adults and children 10 years and older with Type 2 diabetes. It is typically administered as a daily injection and can help reduce the risk of diabetes-related complications. A generic version of Victoza became available in December 2024.
- Saxenda: Saxenda also contains liraglutide, but it is specifically approved for weight management in adults and in children ages 12 and older who are obese. A generic version of Saxenda launched in August 2025, the first FDA-approved generic GLP-1 indicated for weight loss.
- Mounjaro: Mounjaro is a dual-action drug that contains tirzepatide, which is approved for the treatment of Type 2 diabetes. It targets both GLP-1 and GIP receptors, which may improve blood sugar levels and promote weight loss.
- Zepbound: Zepbound, another medication containing tirzepatide, is specifically approved for weight loss in adults with obesity or overweight with a weight-related condition. In December 2024, it became the first FDA-approved prescription drug for obstructive sleep apnea in adults with obesity.
These medications may differ in how they’re taken and what they’re used for. For people with Type 2 diabetes or obesity, there are various options to choose from. However, diabetes medications and weight loss drugs can cause different side effects, have different costs, and may work differently for each person.
Victoza coupons, Saxenda coupons, Mounjaro coupons, Zepbound coupons
Bottom line
A true generic form of Ozempic is not yet available, as the drug remains under patent protection until at least 2033. Although some compounded forms of semaglutide are marketed as cheaper alternatives, they may not be FDA approved and could pose risks, such as improper dosing or unapproved ingredients.
Use caution when considering compounded semaglutide, and consult a healthcare provider for the safest treatment option. In the future, once the patent expires, a legitimate generic version could offer a safer and more affordable alternative for managing diabetes or weight loss.
- Current and resolved drug shortages and discontinuations reported to the FDA, Food and Drug Administration (2024)
- Regulatory framework for compounded preparations, National Academies Press (2020)
- Clinical and legal considerations in pharmaceutical compounding, The Journal of Clinical and Aesthetic Dermatology (2023)
- FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024)
- Medications containing semaglutide marketed for Type 2 diabetes or weight loss, Food and Drug Administration (2024)
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025)